nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftazidime—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.286	0.406	CbGbCtD
Ceftazidime—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.216	0.308	CbGbCtD
Ceftazidime—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.114	0.162	CbGbCtD
Ceftazidime—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.088	0.125	CbGbCtD
Ceftazidime—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.000479	0.00163	CcSEcCtD
Ceftazidime—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.000478	0.00163	CcSEcCtD
Ceftazidime—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.000478	0.00162	CcSEcCtD
Ceftazidime—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.000475	0.00161	CcSEcCtD
Ceftazidime—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.000475	0.00161	CcSEcCtD
Ceftazidime—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000471	0.0016	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000469	0.00159	CcSEcCtD
Ceftazidime—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.000469	0.00159	CcSEcCtD
Ceftazidime—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000468	0.00159	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000468	0.00159	CcSEcCtD
Ceftazidime—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.000467	0.00159	CcSEcCtD
Ceftazidime—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000466	0.00158	CcSEcCtD
Ceftazidime—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000465	0.00158	CcSEcCtD
Ceftazidime—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.000465	0.00158	CcSEcCtD
Ceftazidime—Pain—Stavudine—acquired immunodeficiency syndrome	0.000463	0.00157	CcSEcCtD
Ceftazidime—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000463	0.00157	CcSEcCtD
Ceftazidime—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000462	0.00157	CcSEcCtD
Ceftazidime—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000461	0.00157	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000461	0.00157	CcSEcCtD
Ceftazidime—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00046	0.00156	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000459	0.00156	CcSEcCtD
Ceftazidime—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000457	0.00155	CcSEcCtD
Ceftazidime—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.000457	0.00155	CcSEcCtD
Ceftazidime—Pain—Abacavir—acquired immunodeficiency syndrome	0.000456	0.00155	CcSEcCtD
Ceftazidime—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000454	0.00154	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000454	0.00154	CcSEcCtD
Ceftazidime—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.00045	0.00153	CcSEcCtD
Ceftazidime—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000448	0.00152	CcSEcCtD
Ceftazidime—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.000447	0.00152	CcSEcCtD
Ceftazidime—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000446	0.00151	CcSEcCtD
Ceftazidime—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000446	0.00151	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000444	0.00151	CcSEcCtD
Ceftazidime—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000443	0.00151	CcSEcCtD
Ceftazidime—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000443	0.00151	CcSEcCtD
Ceftazidime—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000443	0.00151	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000443	0.00151	CcSEcCtD
Ceftazidime—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000441	0.0015	CcSEcCtD
Ceftazidime—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.000439	0.00149	CcSEcCtD
Ceftazidime—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000439	0.00149	CcSEcCtD
Ceftazidime—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000438	0.00149	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000436	0.00148	CcSEcCtD
Ceftazidime—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000435	0.00148	CcSEcCtD
Ceftazidime—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000434	0.00148	CcSEcCtD
Ceftazidime—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000432	0.00147	CcSEcCtD
Ceftazidime—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000432	0.00147	CcSEcCtD
Ceftazidime—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000431	0.00147	CcSEcCtD
Ceftazidime—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00043	0.00146	CcSEcCtD
Ceftazidime—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00043	0.00146	CcSEcCtD
Ceftazidime—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00043	0.00146	CcSEcCtD
Ceftazidime—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000429	0.00146	CcSEcCtD
Ceftazidime—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000429	0.00146	CcSEcCtD
Ceftazidime—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000429	0.00146	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000429	0.00146	CcSEcCtD
Ceftazidime—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000428	0.00146	CcSEcCtD
Ceftazidime—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000428	0.00146	CcSEcCtD
Ceftazidime—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000427	0.00145	CcSEcCtD
Ceftazidime—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000427	0.00145	CcSEcCtD
Ceftazidime—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000425	0.00145	CcSEcCtD
Ceftazidime—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000424	0.00144	CcSEcCtD
Ceftazidime—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000423	0.00144	CcSEcCtD
Ceftazidime—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000423	0.00144	CcSEcCtD
Ceftazidime—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000423	0.00144	CcSEcCtD
Ceftazidime—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000422	0.00143	CcSEcCtD
Ceftazidime—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000422	0.00143	CcSEcCtD
Ceftazidime—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.00042	0.00143	CcSEcCtD
Ceftazidime—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000413	0.0014	CcSEcCtD
Ceftazidime—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000412	0.0014	CcSEcCtD
Ceftazidime—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000407	0.00138	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000406	0.00138	CcSEcCtD
Ceftazidime—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000406	0.00138	CcSEcCtD
Ceftazidime—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000405	0.00138	CcSEcCtD
Ceftazidime—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000404	0.00137	CcSEcCtD
Ceftazidime—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000403	0.00137	CcSEcCtD
Ceftazidime—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000403	0.00137	CcSEcCtD
Ceftazidime—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000402	0.00137	CcSEcCtD
Ceftazidime—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000401	0.00136	CcSEcCtD
Ceftazidime—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.0004	0.00136	CcSEcCtD
Ceftazidime—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000399	0.00136	CcSEcCtD
Ceftazidime—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000397	0.00135	CcSEcCtD
Ceftazidime—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000397	0.00135	CcSEcCtD
Ceftazidime—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000397	0.00135	CcSEcCtD
Ceftazidime—Rash—Didanosine—acquired immunodeficiency syndrome	0.000393	0.00134	CcSEcCtD
Ceftazidime—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000393	0.00134	CcSEcCtD
Ceftazidime—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000393	0.00134	CcSEcCtD
Ceftazidime—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000393	0.00134	CcSEcCtD
Ceftazidime—Headache—Didanosine—acquired immunodeficiency syndrome	0.000391	0.00133	CcSEcCtD
Ceftazidime—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000389	0.00132	CcSEcCtD
Ceftazidime—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000388	0.00132	CcSEcCtD
Ceftazidime—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000386	0.00131	CcSEcCtD
Ceftazidime—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000386	0.00131	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000385	0.00131	CcSEcCtD
Ceftazidime—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000384	0.00131	CcSEcCtD
Ceftazidime—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000384	0.00131	CcSEcCtD
Ceftazidime—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000384	0.0013	CcSEcCtD
Ceftazidime—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000383	0.0013	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000379	0.00129	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000378	0.00128	CcSEcCtD
Ceftazidime—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000378	0.00128	CcSEcCtD
Ceftazidime—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000376	0.00128	CcSEcCtD
Ceftazidime—Pain—Indinavir—acquired immunodeficiency syndrome	0.000374	0.00127	CcSEcCtD
Ceftazidime—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000374	0.00127	CcSEcCtD
Ceftazidime—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000374	0.00127	CcSEcCtD
Ceftazidime—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000372	0.00126	CcSEcCtD
Ceftazidime—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000372	0.00126	CcSEcCtD
Ceftazidime—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000372	0.00126	CcSEcCtD
Ceftazidime—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000371	0.00126	CcSEcCtD
Ceftazidime—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000371	0.00126	CcSEcCtD
Ceftazidime—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000371	0.00126	CcSEcCtD
Ceftazidime—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00037	0.00126	CcSEcCtD
Ceftazidime—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000369	0.00125	CcSEcCtD
Ceftazidime—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000365	0.00124	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000365	0.00124	CcSEcCtD
Ceftazidime—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000359	0.00122	CcSEcCtD
Ceftazidime—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000359	0.00122	CcSEcCtD
Ceftazidime—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000358	0.00122	CcSEcCtD
Ceftazidime—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000358	0.00122	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000358	0.00122	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000357	0.00121	CcSEcCtD
Ceftazidime—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000357	0.00121	CcSEcCtD
Ceftazidime—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000357	0.00121	CcSEcCtD
Ceftazidime—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000356	0.00121	CcSEcCtD
Ceftazidime—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000355	0.00121	CcSEcCtD
Ceftazidime—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000354	0.0012	CcSEcCtD
Ceftazidime—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000354	0.0012	CcSEcCtD
Ceftazidime—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000353	0.0012	CcSEcCtD
Ceftazidime—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000353	0.0012	CcSEcCtD
Ceftazidime—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000351	0.00119	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000348	0.00118	CcSEcCtD
Ceftazidime—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000348	0.00118	CcSEcCtD
Ceftazidime—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000346	0.00118	CcSEcCtD
Ceftazidime—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000346	0.00118	CcSEcCtD
Ceftazidime—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000345	0.00117	CcSEcCtD
Ceftazidime—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000345	0.00117	CcSEcCtD
Ceftazidime—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000345	0.00117	CcSEcCtD
Ceftazidime—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000344	0.00117	CcSEcCtD
Ceftazidime—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000343	0.00116	CcSEcCtD
Ceftazidime—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000342	0.00116	CcSEcCtD
Ceftazidime—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000342	0.00116	CcSEcCtD
Ceftazidime—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000342	0.00116	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000342	0.00116	CcSEcCtD
Ceftazidime—Rash—Stavudine—acquired immunodeficiency syndrome	0.000342	0.00116	CcSEcCtD
Ceftazidime—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000341	0.00116	CcSEcCtD
Ceftazidime—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00034	0.00116	CcSEcCtD
Ceftazidime—Headache—Stavudine—acquired immunodeficiency syndrome	0.000339	0.00115	CcSEcCtD
Ceftazidime—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000339	0.00115	CcSEcCtD
Ceftazidime—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000338	0.00115	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000338	0.00115	CcSEcCtD
Ceftazidime—Rash—Abacavir—acquired immunodeficiency syndrome	0.000336	0.00114	CcSEcCtD
Ceftazidime—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000336	0.00114	CcSEcCtD
Ceftazidime—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000336	0.00114	CcSEcCtD
Ceftazidime—Headache—Abacavir—acquired immunodeficiency syndrome	0.000334	0.00114	CcSEcCtD
Ceftazidime—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000333	0.00113	CcSEcCtD
Ceftazidime—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000333	0.00113	CcSEcCtD
Ceftazidime—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00033	0.00112	CcSEcCtD
Ceftazidime—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000329	0.00112	CcSEcCtD
Ceftazidime—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000329	0.00112	CcSEcCtD
Ceftazidime—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000329	0.00112	CcSEcCtD
Ceftazidime—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000329	0.00112	CcSEcCtD
Ceftazidime—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000327	0.00111	CcSEcCtD
Ceftazidime—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000327	0.00111	CcSEcCtD
Ceftazidime—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000326	0.00111	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000324	0.0011	CcSEcCtD
Ceftazidime—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000323	0.0011	CcSEcCtD
Ceftazidime—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000323	0.0011	CcSEcCtD
Ceftazidime—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000322	0.00109	CcSEcCtD
Ceftazidime—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000322	0.00109	CcSEcCtD
Ceftazidime—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000317	0.00108	CcSEcCtD
Ceftazidime—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000316	0.00108	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000316	0.00107	CcSEcCtD
Ceftazidime—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000314	0.00107	CcSEcCtD
Ceftazidime—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000314	0.00107	CcSEcCtD
Ceftazidime—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000313	0.00106	CcSEcCtD
Ceftazidime—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000313	0.00106	CcSEcCtD
Ceftazidime—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000313	0.00106	CcSEcCtD
Ceftazidime—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000311	0.00106	CcSEcCtD
Ceftazidime—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00031	0.00105	CcSEcCtD
Ceftazidime—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000305	0.00104	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000304	0.00103	CcSEcCtD
Ceftazidime—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000302	0.00103	CcSEcCtD
Ceftazidime—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000301	0.00102	CcSEcCtD
Ceftazidime—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.0003	0.00102	CcSEcCtD
Ceftazidime—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000299	0.00102	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000299	0.00102	CcSEcCtD
Ceftazidime—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000297	0.00101	CcSEcCtD
Ceftazidime—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000297	0.00101	CcSEcCtD
Ceftazidime—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000295	0.001	CcSEcCtD
Ceftazidime—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000293	0.000995	CcSEcCtD
Ceftazidime—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000292	0.000991	CcSEcCtD
Ceftazidime—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000291	0.000988	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00029	0.000986	CcSEcCtD
Ceftazidime—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00029	0.000984	CcSEcCtD
Ceftazidime—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000289	0.000983	CcSEcCtD
Ceftazidime—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000289	0.000983	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000288	0.000979	CcSEcCtD
Ceftazidime—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000287	0.000977	CcSEcCtD
Ceftazidime—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000283	0.000962	CcSEcCtD
Ceftazidime—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00028	0.000952	CcSEcCtD
Ceftazidime—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00028	0.000951	CcSEcCtD
Ceftazidime—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00028	0.00095	CcSEcCtD
Ceftazidime—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000278	0.000947	CcSEcCtD
Ceftazidime—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000278	0.000947	CcSEcCtD
Ceftazidime—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000278	0.000946	CcSEcCtD
Ceftazidime—Rash—Indinavir—acquired immunodeficiency syndrome	0.000276	0.000938	CcSEcCtD
Ceftazidime—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000276	0.000937	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000275	0.000934	CcSEcCtD
Ceftazidime—Headache—Indinavir—acquired immunodeficiency syndrome	0.000274	0.000932	CcSEcCtD
Ceftazidime—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000274	0.00093	CcSEcCtD
Ceftazidime—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000271	0.00092	CcSEcCtD
Ceftazidime—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.000917	CcSEcCtD
Ceftazidime—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000267	0.000907	CcSEcCtD
Ceftazidime—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000266	0.000903	CcSEcCtD
Ceftazidime—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000266	0.000903	CcSEcCtD
Ceftazidime—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000263	0.000894	CcSEcCtD
Ceftazidime—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.00089	CcSEcCtD
Ceftazidime—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000261	0.000887	CcSEcCtD
Ceftazidime—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000261	0.000886	CcSEcCtD
Ceftazidime—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00026	0.000884	CcSEcCtD
Ceftazidime—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.000882	CcSEcCtD
Ceftazidime—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000259	0.000881	CcSEcCtD
Ceftazidime—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000259	0.00088	CcSEcCtD
Ceftazidime—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000252	0.000855	CcSEcCtD
Ceftazidime—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00025	0.000851	CcSEcCtD
Ceftazidime—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00025	0.000848	CcSEcCtD
Ceftazidime—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.000847	CcSEcCtD
Ceftazidime—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000249	0.000847	CcSEcCtD
Ceftazidime—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000248	0.000843	CcSEcCtD
Ceftazidime—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.000842	CcSEcCtD
Ceftazidime—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000246	0.000835	CcSEcCtD
Ceftazidime—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.000823	CcSEcCtD
Ceftazidime—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000241	0.000819	CcSEcCtD
Ceftazidime—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000238	0.000808	CcSEcCtD
Ceftazidime—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000235	0.000799	CcSEcCtD
Ceftazidime—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.000792	CcSEcCtD
Ceftazidime—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.000791	CcSEcCtD
Ceftazidime—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000231	0.000784	CcSEcCtD
Ceftazidime—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000231	0.000784	CcSEcCtD
Ceftazidime—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.000782	CcSEcCtD
Ceftazidime—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000229	0.000779	CcSEcCtD
Ceftazidime—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.000761	CcSEcCtD
Ceftazidime—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.000755	CcSEcCtD
Ceftazidime—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.000755	CcSEcCtD
Ceftazidime—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.000754	CcSEcCtD
Ceftazidime—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.00075	CcSEcCtD
Ceftazidime—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.000739	CcSEcCtD
Ceftazidime—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.000726	CcSEcCtD
Ceftazidime—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.00072	CcSEcCtD
Ceftazidime—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.00072	CcSEcCtD
Ceftazidime—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.000716	CcSEcCtD
Ceftazidime—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.000711	CcSEcCtD
Ceftazidime—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.000679	CcSEcCtD
Ceftazidime—SLC15A1—digestive system—acquired immunodeficiency syndrome	0.000149	0.0835	CbGeAlD
Ceftazidime—SLC15A2—retina—acquired immunodeficiency syndrome	0.000133	0.0743	CbGeAlD
Ceftazidime—SLC15A1—vagina—acquired immunodeficiency syndrome	0.000132	0.0737	CbGeAlD
Ceftazidime—SLC22A5—retina—acquired immunodeficiency syndrome	0.000116	0.0646	CbGeAlD
Ceftazidime—SLC22A6—brain—acquired immunodeficiency syndrome	0.000106	0.0593	CbGeAlD
Ceftazidime—SLC22A5—skin of body—acquired immunodeficiency syndrome	0.000102	0.0567	CbGeAlD
Ceftazidime—SLC15A2—blood—acquired immunodeficiency syndrome	8.9e-05	0.0497	CbGeAlD
Ceftazidime—SLC15A2—spinal cord—acquired immunodeficiency syndrome	8.57e-05	0.0479	CbGeAlD
Ceftazidime—SLC15A2—vagina—acquired immunodeficiency syndrome	8.25e-05	0.0461	CbGeAlD
Ceftazidime—SLC22A5—digestive system—acquired immunodeficiency syndrome	8.12e-05	0.0454	CbGeAlD
Ceftazidime—SLC15A2—lung—acquired immunodeficiency syndrome	7.8e-05	0.0436	CbGeAlD
Ceftazidime—SLC22A5—blood—acquired immunodeficiency syndrome	7.74e-05	0.0432	CbGeAlD
Ceftazidime—SLC22A5—spinal cord—acquired immunodeficiency syndrome	7.46e-05	0.0417	CbGeAlD
Ceftazidime—Ceftriaxone—ALB—acquired immunodeficiency syndrome	7.36e-05	0.374	CrCbGaD
Ceftazidime—SLC15A2—nervous system—acquired immunodeficiency syndrome	7.22e-05	0.0404	CbGeAlD
Ceftazidime—SLC22A5—vagina—acquired immunodeficiency syndrome	7.17e-05	0.0401	CbGeAlD
Ceftazidime—SLC15A2—central nervous system—acquired immunodeficiency syndrome	6.96e-05	0.0388	CbGeAlD
Ceftazidime—SLC22A5—lung—acquired immunodeficiency syndrome	6.79e-05	0.0379	CbGeAlD
Ceftazidime—Cefalotin—ALB—acquired immunodeficiency syndrome	6.44e-05	0.328	CrCbGaD
Ceftazidime—Cephalexin—ALB—acquired immunodeficiency syndrome	5.86e-05	0.298	CrCbGaD
Ceftazidime—SLC15A2—brain—acquired immunodeficiency syndrome	5.52e-05	0.0308	CbGeAlD
Ceftazidime—SLC15A2—lymph node—acquired immunodeficiency syndrome	5.34e-05	0.0298	CbGeAlD
Ceftazidime—SLC22A5—brain—acquired immunodeficiency syndrome	4.8e-05	0.0268	CbGeAlD
Ceftazidime—SLC22A5—lymph node—acquired immunodeficiency syndrome	4.64e-05	0.0259	CbGeAlD
